To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Dyslexia treatment
Because dyslexia's most salient symptom is childhood difficulty with learning to read, the most common form of treatment is through specialized tutoring or teaching tailored to meet the particular learning characteristics of the student. Most teaching is geared to remediating specific areas of weakness, such as addressing difficulties with phonetic decoding by providing phonics-based tutoring. Some teaching is geared to specific reading skill areas, such as phonetic decoding; whereas other approaches are more comprehensive in scope, combining techniques to address basic skills along with strategies to improve comprehension and literary appreciation. Many programs are multisensory in design, meaning that instruction includes visual, auditory, and kinesthetic or tactile elements; as it is generally believed that such forms of instruction are more effective for dyslexic learners.[1] Despite claims of some programs to be "research based", there is very little empirical or quantitative research supporting the use of any particular approach to reading instruction as compared to another when used with dyslexic children.[2][3] See alsoReferences
|
||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Dyslexia_treatment". A list of authors is available in Wikipedia. |
- Agilent Technologies and Integrated Diagnostics Enter Strategic Partnership to Develop Protein-Based Assays for Early Disease Detection
- Okra
- “Stretching Rack” for Cells - An ingenious device, only a few micrometers in size, enables to study the reaction of individual biological cells to mechanical stress
- How to achieve and maintain pharmaceutical compliance - Pharmaceutical Compliance Guide
- Johann_Friedrich_Gmelin